Ignite Creation Date:
2024-05-06 @ 7:07 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05908409
Status:
RECRUITING
Last Update Posted:
2023-09-28
First Post:
2023-05-03
Brief Title:
A Phase 12 Study of IDP-121 in Patients With RelapsedRefractory Hematologic Malignancies
Sponsor:
IDP Discovery Pharma SL
Organization:
IDP Discovery Pharma SL
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-05
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12-22
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12-22
Completion Date Type:
ESTIMATED
First Submit Date:
2023-05-03
First Submit QC Date:
June 9 2023
Study First Post Date:
2023-06-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-09-27
Last Update Post Date:
2023-09-28
Last Update Post Date Type:
ACTUAL